A protest over a draft decision not to recommend a new cystic fibrosis drug is due later. Campaigners keen to see Kalydeco introduced across Wales are aiming to make their voices heard outside a meeting of the All Wales Medicines Strategy Group at the Angel Hotel in Abergavenny.
The group will look at the recommendation and decide whether to approve it or not. The drug - which is already available in England, Scotland and Northern Ireland - is the first licensed drug that treats the G551D mutation - the fundamental defect in those with cystic fibrosis.
More top news
Clear skies to come tonight staying mostly dry and feeling chilly.
Guide Dogs Cymru says it's desperate for suitable volunteers to take on puppies and give them their initial stage of training.
A Wrexham man who tried to explain away why he had £20,000 of criminal cash hidden away has received a four year jail sentence.